PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1364750
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1364750
North America Varicose Veins Treatment Market, By Products ; By Treatment Mode ; By Country, Trend Analysis, Competitive Landscape & Forecast, 2019-2029
North America Varicose Veins Treatment Market Size More Than Doubles to Touch USD 791 Million by 2029.
North America varicose veins treatment market is gaining traction because of the rising prevalence of varicose veins and technological advancements in varicose veins treatment.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the North America varicose veins treatment market size at USD 376.2 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the North America varicose veins treatment market size to grow at a CAGR of 11.2% reaching a value of USD 790.96 million by 2029. The increased incidence of varicose veins, numerous technical developments, and accessibility of cutting-edge therapies are major growth factors for the North American varicose veins treatment market. Additionally, high healthcare spending and a growing older population in the region will influence the growth of the North America varicose veins treatment market.
North America Varicose Veins Treatment Market - Overview:
Varicose veins are anomalous, dilated blood vessels brought on by the vessel walls deteriorating. These veins under the skin seemed to be a twisted, bloated cluster of blue or purple veins. Technically, there is no medically accepted treatment for varicose veins. The entire vein is collapsed and blood is diverted to another vein instead of treating a varicose vein. The vein is still present; it is only inactive. In certain cases, the injured vein may be removed by the physicians.
North America Varicose Veins Treatment Market
Segmental Information:
North America Varicose Veins Treatment Market - By Treatment Mode:
Based on treatment mode, the North America varicose veins treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The surgical ligation/stripping accounts for the highest share in the market. The Hopkins Medicine says that surgical ligation surgeries close and shrinks off the varicose veins. The vein is then sealed off and the blood then travels via neighboring veins in its place. It is a minor surgery which improves blood flow and mitigates symptoms like pain and swellings, which influences its growing demand in the market.
Impact of COVID-19 on the North America Varicose Veins Treatment Market
The COVID-19 pandemic slowed the growth of the North America varicose veins treatment market. The United States and Canada were severely affected by the virus outbreak in their respective countries. Hospitals and other medical facilities were overburdened with COVID-19 cases, reducing the number of in-patient treatment of non-COVID-19 patients to avoid exposing visiting patients to hospital-acquired diseases. The immediate postponement of all unnecessary procedures in order to conserve medical resources led to a delay in varicose vein treatments, which in turn constrained market expansion. However, it is projected that the market will expand after COVID-19 as all the postponed varicose vein operations and treatments resume.
Competitive Landscape:
Major players operating in North America varicose veins treatment market include: AngioDynamics, Inc., Vascular Solutions, Inc., Sciton, Inc., Merz Aesthetics, Candela Medical, Teleflex Incorporated, Merit Medical Systems, and Boston Scientific Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the North America Varicose Veins Treatment Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the North America Varicose Veins Treatment Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. North America Varicose Veins Treatment Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising prevalence of Varicose Veins
- 3.2.1.2. Technological advancements in varicose veins treatment
- 3.2.2. Restraints
- 3.2.2.1. High cost of treatment
- 3.2.2.2. Lack of skilled medical professionals
- 3.2.3. Opportunities
- 3.2.3.1. Patient awareness
- 3.2.3.2. Growing demand for minimally invasive procedures
- 3.2.4. Challenges
- 3.2.4.1. Limited Insurance Coverage
- 3.2.4.2. Competition
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. North America Varicose Veins Treatment Market Overview
- 4.1. Market Products & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
- 4.2. Market Share and Forecast
- 4.2.1. By Products
- 4.2.1.1. Ablation Devices
- 4.2.1.1.1. Radiofrequency Ablation Devices
- 4.2.1.1.2. Laser Ablation Devices
- 4.2.1.2. Venous Closure Products
- 4.2.1.3. Surgical Products
- 4.2.2. By Treatment Mode
- 4.2.2.1. Endovenous Ablation
- 4.2.2.2. Injection Sclerotherapy
- 4.2.2.3. Surgical Ligation/Stripping
- 4.2.3. By Country
- 4.2.3.1. United States
- 4.2.3.2. Canada
- 4.2.1. By Products
5. Competitive Landscape
- 5.1. List of Key Players and Their Offerings
- 5.2. North America Varicose Veins Treatment Market Share Analysis, 2022
- 5.3. Competitive Benchmarking, By Operating Parameters
- 5.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
6. Impact of Covid-19 on North America Varicose Veins Treatment Market
7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- 7.1. AngioDynamics, Inc.
- 7.2. Vascular Solutions, Inc.
- 7.3. Sciton, Inc.
- 7.4. Merz Aesthetics
- 7.5. Candela Medical
- 7.6. Teleflex Incorporated
- 7.7. Sciton Inc.
- 7.8. Merit Medical Systems
- 7.9. Boston Scientific Corporation
- 7.10. Other Prominent Players
8. Key Strategic Recommendations
9. Research Methodology
- 9.1. Qualitative Research
- 9.1.1. Primary & Secondary Research
- 9.2. Quantitative Research
- 9.3. Market Breakdown & Data Triangulation
- 9.3.1. Secondary Research
- 9.3.2. Primary Research
- 9.4. Breakdown of Primary Research Respondents, By Country
- 9.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List Figures
- Figure 1 North America Varicose Veins Treatment Segmentation
- Figure 2 North America Varicose Veins Treatment Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2022
- Figure 4 North America Varicose Veins Treatment Market Products, By Value (USD Million), 2019-2029
- Figure 5 North America Varicose Veins Treatment Market Share, By Products, By Value, 2019-2029
- Figure 6 North America Varicose Veins Treatment Market Share, By Treatment Mode, By Value, 2019-2029
- Figure 7 North America Varicose Veins Treatment Market Share, By Country, By Value, 2019-2029
List of Tables
- Table 1 North America Varicose Veins Treatment Market Products, By Value (USD Million), 2019-2029
- Table 2 North America Varicose Veins Treatment Market Share, By Products, By Value, 2019-2029
- Table 3 North America Varicose Veins Treatment Market Share, By Treatment Mode, By Value, 2019-2029
- Table 4 North America Varicose Veins Treatment Market Share, By Country, By Value, 2019-2029
- Table 5 AngioDynamics, Inc. Company Overview
- Table 6 AngioDynamics, Inc. Financial Overview
- Table 7 Vascular Solutions, Inc. Company Overview
- Table 8 Vascular Solutions, Inc. Financial Overview
- Table 9 Sciton, Inc. Company Overview
- Table 10 Sciton, Inc. Financial Overview
- Table 11 Merz Aesthetics Company Overview
- Table 12 Merz Aesthetics Financial Overview
- Table 13 Candela Medical Company Overview
- Table 14 Candela Medical Financial Overview
- Table 15 Teleflex Incorporated Company Overview
- Table 16 Teleflex Incorporated Financial Overview
- Table 17 Sciton Inc. Company Overview
- Table 18 Sciton Inc. Financial Overview
- Table 19 Merit Medical Systems Company Overview
- Table 20 Merit Medical Systems Financial Overview
- Table 21 Boston Scientific Corporation Company Overview
- Table 22 Boston Scientific Corporation Financial Overview
